Advertisement

Determining type 2 diabetes risk factors for the adults: A community based study from Turkey

      Highlights

      • T2D is a disease that hides itself and continued existence for many years without displaying any symptoms.
      • Community-based risk determining studies are important in countries with increasing diabetes rate.
      • FINDRISC can be used as screening tool to identify individuals at high risk for diabetes.

      Abstract

      Aims

      This study aimed to determine risk factors for type 2 diabetes among adults who were not diagnosed with diabetes.

      Methods

      Adults were included in this study within the public activities performed on World Diabetes Day (n = 1872). Data were collected using the FINDRISC questionnaire and a short questionnaire.

      Results

      Participants’ mean age was 39.35 ± 10.40. The mean FINDRISC score was 7.46 ± 4.62, women's mean score was higher than that for men. The FINDRISC score indicates that 7.4% of the participants were in the highrisk group. Among participants, BMI value of 65.1% was 25 kg/m2 and higher, waist circumference of 58% was over the threshold value; and 50.7% did not engage in sufficient physical activity. Of the participants, 9.5% had a history of high blood glucose, families of 38.9% had a history of diabetes. The mean FINDRISC score was in the slightly high category, 121 participants were found likely to be diagnosed with diabetes within ten years if no action was taken.

      Conclusions

      It is recommended the risk screening studies to be conducted and the FINDRISC tool to be used in Turkey, where diabetes prevalence is increasing rapidly, to determine diabetes risks in the early period and to raise social awareness for diabetes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • International Diabetes Federation
        Diabetes Atlas.
        8th ed. 2017 (Available at: http://www.diabetesatlas.org/. (Accessed 28 December 2017))
        • Satman I.
        • Omer B.
        • Tutuncu Y.
        • et al.
        Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults.
        Eur. J. Epidemiol. 2013; 28: 169-180
        • International Diabetes Federation
        Clinical Guidelines Task Force: Global Guideline for Type 2 Diabetes.
        2012 (https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes. (Accessed 10 May 2017))
        • International Diabetes Federation
        IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care.
        2017 (Available at: https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.html. (Accessed 01 August 2017))
        • American Diabetes Association
        Standards of medical care in diabetes. Prevention or delay of type 2 diabetes.
        Diabetes Care. 2017; 40: S44-S47
        • World Health Organization
        Global Report on Diabetes.
        2016 (Available at: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf. (Accessed 12 May 2017))
        • Centers for Disease Control and Prevention
        National Diabetes Prevention Program.
        2016 (Available at: https://www.cdc.gov/diabetes/prevention/index.html. (Accessed 10 April 2017))
        • West B.
        • Parikh P.
        • Arniella G.
        • et al.
        Observations and recommendations for community-based diabetes screenings.
        Diabetes Educ. 2010; 36: 887-893
        • Grech M.
        • Chaney D.
        Screening for type 2 diabetes and pre-diabetes in general practice: a descriptive study of Maltese practices.
        Prim. Care Diabetes. 2014; 8: 224-230
        • American Diabetes Association
        Screening for type 2 diabetes.
        Diabetes Care. 2000; 1: S20-S23
        • Thoopputra T.
        • Newby D.
        • Schneider J.
        • et al.
        Survey of diabetes risk assessment tools: concepts, structure and performance.
        Diabetes Metab. Res. Rev. 2012; 28: 485-498
        • Tuomilehto J.
        • Lindström J.
        • Hellmich M.
        • et al.
        Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus—the STOP-NIDDM risk-score.
        Diabetes Res. Clin. Pract. 2010; 87: 267-274
        • Lindström J.
        • Tuomilehto J.
        The diabetes risk score a practical tool to predict type 2 diabetes risk.
        Diabetes Care. 2003; 26: 725-731
        • Brown N.
        • Critchley C.
        • Bogowicz P.
        Risk scores based on self-reported or available clinical data to detect undiagnosed type 2 diabetes: a systematic review.
        Diabetes Res. Clin. Pract. 2012; 98: 369-385
        • Al-Lawati J.A.
        • Tuomilehto J.
        Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East.
        Diabetes Res. Clin. Pract. 2007; 77: 438-444
      1. The Society of Endocrinology and Metabolism of Turkey, Diagnosis, Treatment and Monitoring Guideline of Diabetes Mellitus and Its Complications-2017. Available at: http://www.turkendokrin.org/files/DIYABET2017_web.pdf. (Accessed 17 May 2017).

        • Turkey Diabetes Foundation
        Prediabetes Diagnosis and Treatment Guidelines.
        2017 (Available at: http://www.turkdiab.org/admin/PICS/webfiles/Prediyabet_Tani_ve_Tedavi_Rehberi.pdf. (Accessed 17 May 2017))
        • Zhang L.
        • Zhang Z.
        • Zhang Y.
        • et al.
        Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. Adults by gender and race: NHANES 1999–2010.
        PLoS One. 2014; 9e97865https://doi.org/10.1371/journal.pone.0097865
        • Janghorbani M.
        • Adineh H.
        • Amini M.
        Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study.
        Diabetes Res. Clin. Pract. 2013; 102: 202-209
        • Bayındır Çevik A.
        • Karaaslan M.
        • Koçan S.
        • et al.
        Prevalence and screening for risk factors of type 2 diabetes in Rize, Nourtheast Turkey: findings from a population-based study.
        Prim. Care Diabetes. 2016; 10: 10-18
        • Kutlu R.
        • Sayın S.
        • Koçak A.
        Applicability of the Finnish Diabetes Risk (FINDRISC) as a screening tool for type 2 diabetes mellitus.
        Konuralp Tıp Dergisi. 2016; 8: 158-166
        • Erdoğan G.
        • Coşansu G.
        Determination of the Risk Factors for Diabetes and Health-promoting Lifestyle in Taxi Drivers. Master’s Thesis.
        İstanbul University, Institute of Health Sciences, Department of Public Health Nursing, İstanbul2016
        • Makrilakis K.
        • Liatis S.
        • Grammatikou S.
        • et al.
        Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
        Diabetes Metab. J. 2011; 37: 144-151
        • Awad A.I.
        • Alsaleh F.M.
        10-year risk estimation for type 2 diabetes mellitus and coronary heart disease in Kuwait: a cross-sectional population-based study.
        PLoS One. 2015; 10e0116742https://doi.org/10.1371/journal.pone.0116742
        • Alebiosu O.C.
        • Familoni O.B.
        • Ogunsemi O.O.
        • et al.
        Community based diabetes risk assessment in Ogun state, Nigeria (World Diabetes Foundation project 08-321).
        Indian J. Endocrinol. Metab. 2013; 17: 653-658
        • Väätäinen S.
        • Cederberg H.
        • Roine R.
        • et al.
        Does future diabetes risk ımpair current quality of life? A cross-sectional study of health-related quality of life in relation to the Finnish Diabetes Risk Score (FINDRISC).
        PLoS One. 2016; 11e0147898https://doi.org/10.1371/journal.pone.0147898
        • Akyil R.C.
        • Miloglu O.
        • Olgun N.
        • et al.
        A comparison of three different diabetes screening methods among dental patients in Turkey.
        Pak. J. Med. Sci. 2014; 30: 65-69
        • Tankova T.
        • Chakarova N.
        • Atanassova I.
        • et al.
        Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes.
        Diabetes Res. Clin. Pract. 2011; 92: 46-52
        • Viitasalo K.
        • Lindström J.
        • Hemiö K.
        • et al.
        Occupational health care identifies risk for type 2 diabetes and cardiovascular disease.
        Prim. Care Diabetes. 2012; 6: 95-102
      2. Turkey Nutrition and Health Survey 2010: Status and Assessment of Nutritional Habits. Available at: http://www.sagem.gov.tr/TBSA_Beslenme_Yayini.pdf. (Accessed 01 June 2016).